Serum Levels of sRAGE Are Associated with Body Measurements, but Not Glycemic Parameters in Patients with Prediabetes.
BACKGROUNDOur aim was to assess serum levels of the soluble receptor for advanced glycation end products (sRAGE) and to examine their association with anthropometric and metabolic parameters in patients with prediabetes and obese controls.
METHODSThe two study groups were composed of 42 patients with prediabetes and diabetic neuropathy and 42 age-, gender-, body weight (BW)-, and body mass index (BMI)-matched obese adults as the control group. Prediabetes was diagnosed by the following criteria issued by the American Diabetes Association: impaired fasting glucose [fasting plasma glucose (FPG) level of 100-125 mg/dL], impaired glucose tolerance (2 hr plasma glucose level of 140-199 mg/dL after a 75 grams oral glucose challenge), or a glycated hemoglobin (HbA1C) level of 5.7%-6.4%.
RESULTSThere were no differences between the groups in terms of age, gender distribution, BW, or BMI. Despite these similarities, patients with prediabetes had higher FPG, HbA1c, and 2-hr postchallenge glucose levels, higher systolic and diastolic blood pressure, and larger waist and hip circumferences compared with the obese controls. Lipid measurements, complete blood counts, kidney and liver function tests, high-sensitivity C-reactive protein, and sRAGE levels were similar between the two groups. We found significant negative correlations between sRAGE levels and BW, BMI, waist and hip circumferences, waist-to-hip ratios, and low-density lipoprotein (LDL) cholesterol levels. There were no significant correlations with other parameters, including demographic, metabolic, and blood pressure measurements.
CONCLUSIONSIn contrast to glycemic parameters, serum levels of sRAGE were negatively correlated with body measurements indicative of obesity in the prediabetic state. In addition, the negative correlation with LDL cholesterol levels suggests that sRAGE has a more robust association with metabolic syndrome than with prediabetes.
1 Department of Endocrinology and Metabolism, Sevket Yilmaz Research and Training Hospital-Bursa , Bursa, Turkey .,
2 Department of Neurology, Sevket Yilmaz Research and Training Hospital-Bursa , Bursa, Turkey .,
3 Department of Internal Medicine, Sevket Yilmaz Research and Training Hospital-Bursa , Bursa, Turkey .,
4 Department of Biochemistry, Sevket Yilmaz Research and Training Hospital-Bursa , Bursa, Turkey .,
1 Department of Endocrinology and Metabolism, Sevket Yilmaz Research and Training Hospital-Bursa , Bursa, Turkey .
4 Department of Biochemistry, Sevket Yilmaz Research and Training Hospital-Bursa , Bursa, Turkey .
Body Mass Index
Glucose Tolerance Test
Glycated Hemoglobin A
Predictive Value of Tests
Receptor for Advanced Glycation End Products
Pub Type(s)Journal Article